Want to see JP:4918 full AI Analyst Report?
Top Page
Ivy Cosmetics Corporation
(4918)
Select Model
Select Model
Rating:68Neutral
Price Target:
¥337.00
▼(-0.59% Downside)
Action:Reiterated
Date:06/18/26
The score is driven primarily by improved financial performance (restored profitability, stronger balance sheet, and positive cash generation) and supported by favorable valuation (low P/E and strong dividend yield). Offsetting these positives, technical signals are mixed with negative MACD and the price still below longer-term moving averages, and fundamentals show uneven revenue and cash-flow stability.
Positive Factors
High gross and restored net margins
Sustained gross margins near 70% and restored net margins (~6%) indicate durable product-level profitability and pricing power. High gross margins provide a structural cushion against cost inflation, while positive net margins support reinvestment, dividends and long‑term viability of core product lines.
Negative Factors
Uneven revenue growth; recent decline
A ~-9.8% revenue drop in 2026 after prior strength indicates top-line inconsistency that can erode operating leverage and pressure margins over time. Without sustainable revenue reacceleration, investments in brand, distribution and R&D may not scale, risking slower long‑term growth and returns.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross and restored net margins
Sustained gross margins near 70% and restored net margins (~6%) indicate durable product-level profitability and pricing power. High gross margins provide a structural cushion against cost inflation, while positive net margins support reinvestment, dividends and long‑term viability of core product lines.
Read all positive factors
Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥1.64B
Dividend YieldN/A
Average Volume (3M)15.29K
Price to Earnings (P/E)11.5
Beta (1Y)0.63
Revenue Growth-9.84%
EPS GrowthN/A
CountryJP
Employees179
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)24.01
Shares Outstanding6,414,000
10 Day Avg. Volume19,010
30 Day Avg. Volume15,293
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.75
Price to Sales (P/S)0.75
P/FCF Ratio5.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ivy Cosmetics Corporation Business Overview & Revenue Model
Company Description
Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, ...
How the Company Makes Money
Ivy Cosmetics Corporation generates revenue primarily through the sale of its beauty and personal care products. These products are distributed through multiple channels, including retail stores, e-commerce platforms, and direct sales. The company...
Ivy Cosmetics Corporation Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.64B | 2.93B | 2.71B | 2.94B | 3.53B |
| Gross Profit | 1.84B | 2.07B | 1.91B | 2.11B | 2.42B |
| EBITDA | 244.93M | 20.62M | 242.60M | -33.16M | 185.13M |
| Net Income | 164.53M | 43.01M | 160.31M | -384.61M | 40.38M |
Balance Sheet | |||||
| Total Assets | 3.64B | 3.57B | 3.57B | 3.85B | 4.49B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 577.94M | 208.73M | 247.67M | 129.38M |
| Total Debt | 278.01M | 211.34M | 451.69M | 1.05B | 1.18B |
| Total Liabilities | 1.00B | 1.10B | 1.33B | 1.87B | 2.22B |
| Stockholders Equity | 2.64B | 2.47B | 2.24B | 1.98B | 2.27B |
Cash Flow | |||||
| Free Cash Flow | 385.37M | 424.68M | 408.70M | 243.33M | -160.58M |
| Operating Cash Flow | 451.04M | 445.94M | 453.06M | 278.59M | -107.06M |
| Investing Cash Flow | -58.15M | -18.43M | 7.30M | -29.30M | 63.30M |
| Financing Cash Flow | 70.61M | -58.27M | -499.31M | -131.00M | 59.71M |
Ivy Cosmetics Corporation Technical Analysis
Neutral
339.00
Price Trends
293.44
Negative
329.41
Negative
328.99
Negative
Market Momentum
1.49
Negative
53.48
Neutral
59.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Neutral. The current price of 339 is above the 20-day moving average (MA) of 274.35, above the 50-day MA of 293.44, and above the 200-day MA of 328.99, indicating a neutral trend. The MACD of 1.49 indicates Negative momentum. The RSI at 53.48 is Neutral, neither overbought nor oversold. The STOCH value of 59.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4918.
Ivy Cosmetics Corporation Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥1.64B | 11.46 | ― | ― | -9.84% | ― | |
67 Neutral | ¥6.46B | 8.49 | ― | 2.38% | 0.66% | 31.88% | |
66 Neutral | ¥5.82B | 40.49 | ― | 1.59% | -6.94% | 251.44% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥5.22B | 24.35 | ― | 1.68% | 4.84% | 57.41% | |
59 Neutral | ¥2.40B | 7.07 | ― | 1.72% | -5.61% | 57.31% | |
52 Neutral | ¥5.33B | 21.23 | ― | ― | -18.19% | -65.57% |
* Consumer Defensive Sector Average
JP:4918
Ivy Cosmetics Corporation
289.00
-27.89
-8.80%
JP:4920
Nippon Shikizai, Inc.
1,145.00
116.00
11.27%
JP:4925
HABA Laboratories, Inc.
1,707.00
88.78
5.49%
JP:4926
C'BON COSMETICS Co., Ltd.
1,220.00
99.77
8.91%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
724.00
-14.01
-1.90%
JP:4934
Premier Anti-Aging Co., Ltd.
611.00
-299.00
-32.86%
Ivy Cosmetics Corporation Corporate Events
Ivy Cosmetics Posts Lower Sales but Stronger Balance Sheet in FY2026
May 14, 2026
Ivy Cosmetics reported a 9.8% decline in net sales to ¥2,641 million for the fiscal year ended March 2026, with operating profit halving to ¥195 million as margins narrowed and ordinary profit dropped similarly. Despite weaker top-line g...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.